Breaking down the details of the Purdue Pharma opioid settlement

The $7.4 billion settlement with Purdue Pharma was approved by a federal judge. Now local governments will vote on whether to sign onto the deal. The maker of OxyContin is accused of fueling the country’s opioid overdose epidemic. Dr. Celine Gounder joins to discuss.